Javascript must be enabled to continue!
INCIDENCE AND PREDICTORS OF ACUTE KIDNEY INJURY (AKI) IN ICU PATIENTS RECEIVING HIGH-DOSE VASOPRESSORS
View through CrossRef
Background: Acute kidney injury (AKI) remains a frequent and serious complication in critically ill patients requiring vasopressor therapy. Hemodynamic instability, elevated lactate levels, and fluid imbalance are major contributors to renal dysfunction. Despite advances in critical care, data on the incidence and predictors of AKI in patients receiving high-dose vasopressors in the ICU are limited, particularly in South Asian clinical settings.
Objective: To determine the incidence and identify key hemodynamic and metabolic predictors of AKI among intensive care unit patients receiving high-dose vasopressors.
Methods: A prospective observational cohort study was conducted at Hameed Latif Hospital, Lahore, over twelve months from january to December 2025. Five hundred adult ICU patients requiring norepinephrine equivalent doses ≥0.1 µg/kg/min for more than six hours were enrolled. AKI was defined using KDIGO criteria. Clinical data, including vasopressor dose, mean arterial pressure (MAP), serum lactate trends, and cumulative fluid balance, were recorded. Multivariate logistic regression identified independent predictors, and associations were expressed as adjusted odds ratios (aORs) with 95% confidence intervals (CIs).
Results: The incidence of AKI was 43.6%, with 25.6% Stage 1, 12.4% Stage 2, and 5.6% Stage 3. Independent predictors of AKI included higher vasopressor dose (aOR 1.48; 95% CI 1.22–1.80), lower MAP (aOR 0.87; 95% CI 0.80–0.94), admission lactate ≥4 mmol/L (aOR 2.35; 95% CI 1.40–3.93), and positive fluid balance ≥2 L by day 3 (aOR 1.91; 95% CI 1.28–2.85). AKI was associated with increased mortality (32.6% vs 15.4%) and longer ICU stay (p < 0.001).
Conclusion: AKI was common in critically ill patients receiving high-dose vasopressors and was strongly linked to hemodynamic instability, hyperlactatemia, and fluid overload. Optimizing vasopressor titration, maintaining adequate MAP, and preventing excessive fluid accumulation may help mitigate AKI risk and improve outcomes.
Keywords: Acute kidney injury, Fluid balance, Hemodynamics, Intensive care units, Lactate, Mean arterial pressure, Vasopressors
Title: INCIDENCE AND PREDICTORS OF ACUTE KIDNEY INJURY (AKI) IN ICU PATIENTS RECEIVING HIGH-DOSE VASOPRESSORS
Description:
Background: Acute kidney injury (AKI) remains a frequent and serious complication in critically ill patients requiring vasopressor therapy.
Hemodynamic instability, elevated lactate levels, and fluid imbalance are major contributors to renal dysfunction.
Despite advances in critical care, data on the incidence and predictors of AKI in patients receiving high-dose vasopressors in the ICU are limited, particularly in South Asian clinical settings.
Objective: To determine the incidence and identify key hemodynamic and metabolic predictors of AKI among intensive care unit patients receiving high-dose vasopressors.
Methods: A prospective observational cohort study was conducted at Hameed Latif Hospital, Lahore, over twelve months from january to December 2025.
Five hundred adult ICU patients requiring norepinephrine equivalent doses ≥0.
1 µg/kg/min for more than six hours were enrolled.
AKI was defined using KDIGO criteria.
Clinical data, including vasopressor dose, mean arterial pressure (MAP), serum lactate trends, and cumulative fluid balance, were recorded.
Multivariate logistic regression identified independent predictors, and associations were expressed as adjusted odds ratios (aORs) with 95% confidence intervals (CIs).
Results: The incidence of AKI was 43.
6%, with 25.
6% Stage 1, 12.
4% Stage 2, and 5.
6% Stage 3.
Independent predictors of AKI included higher vasopressor dose (aOR 1.
48; 95% CI 1.
22–1.
80), lower MAP (aOR 0.
87; 95% CI 0.
80–0.
94), admission lactate ≥4 mmol/L (aOR 2.
35; 95% CI 1.
40–3.
93), and positive fluid balance ≥2 L by day 3 (aOR 1.
91; 95% CI 1.
28–2.
85).
AKI was associated with increased mortality (32.
6% vs 15.
4%) and longer ICU stay (p < 0.
001).
Conclusion: AKI was common in critically ill patients receiving high-dose vasopressors and was strongly linked to hemodynamic instability, hyperlactatemia, and fluid overload.
Optimizing vasopressor titration, maintaining adequate MAP, and preventing excessive fluid accumulation may help mitigate AKI risk and improve outcomes.
Keywords: Acute kidney injury, Fluid balance, Hemodynamics, Intensive care units, Lactate, Mean arterial pressure, Vasopressors.
Related Results
Oxygen management in New Zealand and Australian intensive care units: A knowledge translation study
Oxygen management in New Zealand and Australian intensive care units: A knowledge translation study
<p><b>Background: Knowledge translation literature shows a delay between publication and uptake of research findings into clinical practice. There is uncertainty about ...
Oxygen management in New Zealand and Australian intensive care units: A knowledge translation study
Oxygen management in New Zealand and Australian intensive care units: A knowledge translation study
<p><b>Background: Knowledge translation literature shows a delay between publication and uptake of research findings into clinical practice. There is uncertainty about...
MO331: Acute Kidney Failure as a Risk Factor for Longer Hospital Stay, Renal Replacement Therapy and Mortality: A Public Health System Analysis
MO331: Acute Kidney Failure as a Risk Factor for Longer Hospital Stay, Renal Replacement Therapy and Mortality: A Public Health System Analysis
Abstract
BACKGROUND AND AIMS
Acute kidney failure (AKI) is a well-known risk factor in coronary care unit (CCU) and postoperativ...
Factors associated with acute kidney injury among patients with cancer treated with immune checkpoint inhibitor therapy: A population-based study.
Factors associated with acute kidney injury among patients with cancer treated with immune checkpoint inhibitor therapy: A population-based study.
2584 Background: Cancer immune checkpoint inhibitor (ICI) therapy may be associated with kidney immune-related adverse events (IRAEs) and other causes of acute kidney injury (AKI)...
Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
ObjectivesAcute kidney injury (AKI) is a frequent complication among critical ill patients with COVID-19, but the actual incidence is unknown as AKI-incidence varies from 25% to 89...
#807 Presepsin and procalcitonin levels are associated with acute kidney injury in sepsis patients
#807 Presepsin and procalcitonin levels are associated with acute kidney injury in sepsis patients
Abstract
Background and Aims
Acute kidney injury (AKI) is a leading cause of death in patients with sepsis. Presepsin is a novel...
Late-Onset Acute Kidney Injury is a Poor Prognostic Sign for Severe Burn Patients
Late-Onset Acute Kidney Injury is a Poor Prognostic Sign for Severe Burn Patients
BackgroundAcute kidney injury (AKI) is a morbid complication and the main cause of multiple organ failure and death in severely burned patients. The objective of this study was to ...
Early methotrexate level thresholds predictive of acute kidney injury in patients with b cell lymphomas receiving high-dose methotrexate
Early methotrexate level thresholds predictive of acute kidney injury in patients with b cell lymphomas receiving high-dose methotrexate
Abstract
Background: Methotrexate (MTX) induced acute kidney injury (AKI) occurs in 9% of patients (pts) receiving high ...

